Login / Signup

Classic drugs in the time of new drugs: real-world, long-term outcomes of thiopurine monotherapy in 1016 patients with inflammatory bowel disease.

Ashkan Rezazadeh ArdabiliSteven JeuringZlatan MujagicLiekele OostenbrugMariëlle Romberg-CampsDaisy JonkersAdriaan A van BodegravenMarieke Pierik
Published in: Alimentary pharmacology & therapeutics (2022)
In real-world practice, thiopurine monotherapy remains effective, safe and durable for patients with CD or UC, including in the era of biologics.
Keyphrases
  • patients with inflammatory bowel disease
  • combination therapy
  • open label
  • primary care
  • healthcare
  • drug induced
  • clinical trial
  • quality improvement
  • randomized controlled trial
  • nk cells
  • study protocol